Neutralizing antiviral antibody responses.
Zinkernagel
R M
RM
Institute of Experimental Immunology, Department of Pathology, University Hospital, CH-8091 Zürich, Switzerland.
LaMarre
A
A
Ciurea
A
A
Hunziker
L
L
Ochsenbein
A F
AF
McCoy
K D
KD
Fehr
T
T
Bachmann
M F
MF
Kalinke
U
U
Hengartner
H
H
D000914:Antibodies, Viral / Q000276:immunology*; D019067:Antibody-Dependent Enhancement; D000937:Antigen-Antibody Reactions / Q000276:immunology; D000956:Antigens, Viral / Q000648:ultrastructure; D001402:B-Lymphocytes / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology; D006801:Humans; D007156:Immunologic Memory; D008211:Lymphocyte Cooperation; D011961:Receptors, Fc / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D014612:Vaccines / Q000276:immunology; D014777:Virus Diseases / Q000276:immunology; D014780:Viruses / Q000276:immunology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D011961:Receptors, Fc; D014612:Vaccines; D003165:Complement System Proteins